MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
about
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancermicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentChemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastomaThe effects of microRNA on the absorption, distribution, metabolism and excretion of drugsThe role of cancer stem cells and miRNAs in defining the complexities of brain metastasisRole of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceCharacterization of the Small RNA Transcriptome of the Marine Coccolithophorid, Emiliania huxleyiExploring circulating micro-RNA in the neoadjuvant treatment of breast cancerMiRNAs and miRNA Polymorphisms Modify Drug ResponseMicroRNA‑328 directly targets p21‑activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivityMiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 CellsAssociation between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placentaMicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.Regulation of neutrophil senescence by microRNAs.Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.microRNAs of parasitic helminths - Identification, characterization and potential as drug targets.Implication of microRNAs in drug resistance for designing novel cancer therapymirAct: a web tool for evaluating microRNA activity based on gene expression dataMicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel.Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells.Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and AktBreast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cellsDecreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) ratsMiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin.Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.MicroRNA gene dosage alterations and drug response in lung cancerThe challenge of exploiting ABCG2 in the clinic.Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines.MicroRNA-328 inhibits renal tubular cell epithelial-to-mesenchymal transition by targeting the CD44 in pressure-induced renal fibrosis.miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1Pharmacogenomics of membrane transporters: past, present and futureAntagonism of miR-328 increases the antimicrobial function of macrophages and neutrophils and rapid clearance of non-typeable Haemophilus influenzae (NTHi) from infected lungFibroblast Growth Factor 9 Regulation by MicroRNAs Controls Lung Development and Links DICER1 Loss to the Pathogenesis of Pleuropulmonary Blastoma.MicroRNAs: short non-coding players in cancer chemoresistance.
P2860
Q21195215-95480066-F4EE-4C23-AEC2-9FC1B99F6A27Q26778918-596FC736-C787-4D76-AE20-EEC30EA49123Q26800007-71199504-C1A4-4513-A67D-65F9368468ADQ26822987-DFA9FC2B-F695-4DFD-B4BD-2A15C5D1483CQ26864372-53393618-24BB-41C4-9964-94E42AFD849BQ26865927-2EAB1F10-268B-42A5-9415-AB4B7017F7BCQ27312265-1F30B93B-13BE-47F3-A25B-A24CA78D5416Q28066481-82FA561C-E287-4570-879C-5138C46CE38BQ28079075-BD2BD61E-4E63-49A8-8D5D-7FA2BA6CFCD4Q28268506-9B97B037-6917-46A8-AA71-D8035F5363F6Q28547840-51138BC2-22C8-4852-BA4E-27933ADD1D96Q31133417-256F5E8B-14AE-45C2-A08F-63A7DB3D88E3Q33527586-6BA99BBD-CA4B-4605-BB31-1E282D47C248Q33670486-0E4AFD0E-0E34-48FC-995B-AA4E332BF2A2Q33794911-4688FB57-231C-4BE0-9F63-DAFDE2769663Q33808564-56AAB4C3-0AB3-44F6-92C9-08FB7A034684Q33891809-CF13420C-1B24-4502-972F-B1E98CFDD228Q33892045-13FD1D88-243A-4AE4-BB67-6ACB007CAF42Q33903223-21F9FF31-3B3F-41B7-8AD0-A36A328984F7Q33906518-D6220FC5-8DF2-4C82-B79E-D282E2230E10Q34174258-A4FEB9E1-E097-4812-8971-45BC70DBCEADQ34181200-8FF2E87E-FCA5-4957-800A-4D28F1CECB7CQ34293127-D3ADDE6A-E21B-4D93-9A0B-1FA47BD5642DQ34360047-846287D8-B094-489E-A988-68AD724E24E2Q34486971-61E30AB8-0624-41F6-8AE1-A1DEF49F1E64Q34590182-B65E11C9-65FE-47F4-8555-DD76DCDFB7F1Q34702620-F850FC85-A152-406B-9524-8B8C9D7FFB05Q34834106-CD8EE134-8714-4AF2-BEF8-200701B9F896Q34871636-BB46EF9B-E063-403A-A106-82D7FD6C28D7Q34897598-52B92AEB-B092-4AC5-A09C-851EF9763FDEQ34968909-BE9562B0-752E-4B08-8FD6-E432E28B4B68Q35067605-FC8B54FB-1863-4128-A7E5-2884515F7734Q35171243-0AE345E1-40B3-4914-BDC3-9C8F3715C9A9Q35185566-E21EA1AB-B9F0-4B93-B7F8-65B7B143227BQ35494926-0520CF31-1438-43B0-9D22-DAEC96E732C8Q35592937-FA2049DD-1A4A-426A-969F-4F70926963F2Q35603055-CF4EE6A6-1FC4-424B-8202-243E1910EF12Q35610043-C5A28A7C-7846-4257-A473-227A3DD630A4Q35610562-090DF0F6-6C5A-4E43-BB87-825C78060AF1Q35673637-90F783AE-4DC9-4C99-B5CF-1BBCABD37FED
P2860
MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-328 negatively regula ...... /ABCG2) in human cancer cells.
@en
MicroRNA-328 negatively regulates the expression of breast cancer resistance protein
@nl
type
label
MicroRNA-328 negatively regula ...... /ABCG2) in human cancer cells.
@en
MicroRNA-328 negatively regulates the expression of breast cancer resistance protein
@nl
prefLabel
MicroRNA-328 negatively regula ...... /ABCG2) in human cancer cells.
@en
MicroRNA-328 negatively regulates the expression of breast cancer resistance protein
@nl
P2093
P2860
P356
P1476
MicroRNA-328 negatively regula ...... /ABCG2) in human cancer cells.
@en
P2093
Ai-Ming Yu
Marilyn E Morris
Yu-Zhuo Pan
P2860
P304
P356
10.1124/MOL.108.054163
P577
2009-03-06T00:00:00Z